TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/05/2026
Back to search
Official data from USPTO
XTRULINE MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/07/2026
Trademark type
Combined
Nice classes
10, 40
Filing date
11/10/2016
Registration date
04/10/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2025
Last transaction
06/07/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
Reduit, MU
Examiner
SMITH, BRIDGETT G
Current location
Historical data usage
Mark description
The mark consists of the stylized wording "XTRULINE MEDICAL".
Holders and representatives
Holders
Xtruline Co Ltd
NATEC MEDICAL PRIVATE LIMITED
AB INITIO
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 10Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical and surgical apparatus and instruments for use during surgeryin endoscopic and endovascular procedures ; catheters; balloon catheters; wire guides for catheters; cannulae; stents
Class 40
Extrusion of plastics in the nature of transformation of plastics
Publications
History of USPTO decisions and trademark events.
43 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2026
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/14/2026
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/13/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
03/13/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/23/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
01/23/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
01/23/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/11/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/07/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
06/20/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/10/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/24/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/31/2018
FIMP
FINAL DISPOSITION PROCESSED
07/30/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/10/2018
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/03/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
04/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2018
PUBO
PUBLISHED FOR OPPOSITION
01/23/2018
GPNX
NOTIFICATION PROCESSED BY IB
01/19/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/03/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/17/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/17/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/17/2017
UNDN
UNDELIVERABLE MAIL - NO ACTION TAKEN
07/17/2017
RFNT
REFUSAL PROCESSED BY IB
06/17/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/01/2017
RFRR
REFUSAL PROCESSED BY MPU
06/01/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/17/2017
CNRT
NON-FINAL ACTION WRITTEN
05/16/2017
MAFR
APPLICATION FILING RECEIPT MAILED
05/12/2017
DOCK
ASSIGNED TO EXAMINER
05/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2017
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/05/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/04/2017
Continuous trademark protection
Get notified about every new filing that threatens XTRULINE MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.